- AstraZeneca's dynamic duo wants to dominate in cancer drugs STAT
- Pancreatic cancer therapy sheds light on the disease's ties to BRCA mutation CNN
- ASCO: AZ, Merck's Lynparza fends off pancreatic cancer, cutting progression risk in half FiercePharma
- New drug therapy slows spread of pancreatic cancer: study St. Lucia News Online
- Lynparza stalls pancreatic cancer in patients with BRCA mutations: study CNA
- View full coverage on Google News
by via Top stories - Google News
No comments:
Post a Comment